Results 161 to 170 of about 7,274 (190)

Regulation of poly(ADP-ribose) transferase activity by 2',5'-oligoadenylates.

open access: closedBiochemistry international, 1984
pppA2'pA2'pA appears to be a potent natural noncompetitive inhibitor of poly (ADP-ribose) transferase activity in the histone dependent reaction of ADP-ribosylation with Ki=5 microM. Moreover, it is a noncompetitive inhibitor of the Mg2+ dependent reaction of autoADPRT-ribosylation with Ki=20 microM.
Pivazian Ad   +6 more
openalex   +2 more sources

The effect of inhibitors of ADP-ribose transferase on the concentration of (ADP-ribose)n in vivo

open access: closedBiochemical Society Transactions, 1984
William Mullen   +2 more
openalex   +2 more sources

[(ADP-ribose)n-transferase activity of enterocyte nuclei during radiation injury of small intestine mucosa in rats].

open access: closedUkrainskii biokhimicheskii zhurnal (1978), 1986
The (ADP-ribose)n transferase activity of enterocyte nuclei of small intestine is studied in rats in normal and under radiation injury of intestine mucosa. It is shown that kinetics of [14C]-NAD incorporation into the acid-insoluble fraction of enterocyte nuclei is of a two-step character when the medium contains 1-15 microM of NAD.
Trofimiak Tb   +3 more
openalex   +2 more sources

Effect of phorbol esters on ADP-ribose transferase in cultured mouse lymphoma (L1210) cells

open access: closedBiochemical Society Transactions, 1984
MARK WRIGHTMAN   +2 more
openalex   +2 more sources

Substituted benzamides as poly(adp-ribose) transferase inhibitors: development of new derivatives by using computer graphics techniques

open access: closedPharmacological Research, 1989
Piero Sestili   +7 more
openalex   +4 more sources

Analogues of benzamide as poly(ADP-ribose)transferase inhibitors: A study on structure activity relationships

open access: closedPharmacological Research Communications, 1988
Piero Sestili   +4 more
openalex   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap   +2 more
exaly  

Home - About - Disclaimer - Privacy